Vancomycin-associated acute kidney injury: a narrative review from pathophysiology to clinical application
Vancomycin is the most frequently used antibiotic, accounting for up to 35% of hospitalized
patients with infection, because of its optimal bactericidal effectiveness and relatively low …
patients with infection, because of its optimal bactericidal effectiveness and relatively low …
The risk and clinical implications of antibiotic-associated acute kidney injury: a review of the clinical data for agents with signals from the food and drug administration's …
Antibiotic-associated acute kidney injury (AA-AKI) is quite common, especially among
hospitalized patients; however, little is known about risk factors or mechanisms of why AA …
hospitalized patients; however, little is known about risk factors or mechanisms of why AA …
[HTML][HTML] Vancomycin-associated tubular casts and vancomycin nephrotoxicity
N Tantranont, Y Luque, M Hsiao, C Haute… - Kidney international …, 2021 - Elsevier
Introduction Vancomycin nephrotoxicity is frequent and may be due to drug-induced acute
tubular necrosis (ATN) or tubulointerstitial nephritis (TIN). Vancomycin-associated tubular …
tubular necrosis (ATN) or tubulointerstitial nephritis (TIN). Vancomycin-associated tubular …
Kidney biopsy findings in vancomycin-induced acute kidney injury: A pooled analysis
I Bellos, V Pergialiotis, DN Perrea - International Urology and Nephrology, 2022 - Springer
Background Acute kidney injury represents a major adverse effect of vancomycin
administration. The aim of the present study is to accumulate all biopsy-proven cases of …
administration. The aim of the present study is to accumulate all biopsy-proven cases of …
Mapping adverse outcome pathways for kidney injury as a basis for the development of mechanism-based animal-sparing approaches to assessment of …
A Mally, S Jarzina - Frontiers in Toxicology, 2022 - frontiersin.org
In line with recent OECD activities on the use of AOPs in developing Integrated Approaches
to Testing and Assessment (IATAs), it is expected that systematic mapping of AOPs leading …
to Testing and Assessment (IATAs), it is expected that systematic mapping of AOPs leading …
Association between trough serum vancomycin concentration and vancomycin-associated acute kidney injury and 30-day mortality in critically ill elderly adults
J Chen, J Lin, J Weng, Y Ju, Y Li - BMC Infectious Diseases, 2024 - Springer
Background Vancomycin-associated acute kidney injury (VA-AKI) is the most clinically
relevant side effect of vancomycin. The objective of this study was to investigate the …
relevant side effect of vancomycin. The objective of this study was to investigate the …
Vancomycin nephrotoxicity causing renal transplant acute kidney injury
N Tantranont, S Hebert, LD Truong - Transplantation Proceedings, 2021 - Elsevier
Nephrotoxicity is a rather frequent side effect of vancomycin treatment. Attributes of
vancomycin nephrotoxicity (VN) are well documented, including its clinical manifestations …
vancomycin nephrotoxicity (VN) are well documented, including its clinical manifestations …
[PDF][PDF] Urinalysis: Sediment examination, currently, a liquid kidney biopsy
GMT Gomes - Nephrol Renal Dis, 2020 - researchgate.net
The current article aims to assist in understanding the importance of urinalysis, more
specifically, urinary sediment examination, in the diagnosis and monitoring of kidney …
specifically, urinary sediment examination, in the diagnosis and monitoring of kidney …
[PDF][PDF] Farmácia Vilalva, Santo Tirso e Serviços Farmacêuticos do Trofa Saúde Hospital da Trofa-Grupo Trofa Saúde, Trofa
LFD Araújo - 2024 - repositorio-aberto.up.pt
Este Relatório de Estágio reflete a experiência adquirida durante o meu estágio curricular
realizado na Farmácia Vilalva, entre janeiro e julho e no Hospital Trofa Saúde, entre maio e …
realizado na Farmácia Vilalva, entre janeiro e julho e no Hospital Trofa Saúde, entre maio e …
Vancomycin-associated cast nephropathy: reality or fantasy?
MB Stokes, JS Stevens - Kidney360, 2022 - journals.lww.com
Vancomycin is a glycopeptide antibiotic commonly used for severe gram-positive bacterial
infections, notably methicillin-resistant Staphylococcus aureus. AKI occurs in 5%-43% of …
infections, notably methicillin-resistant Staphylococcus aureus. AKI occurs in 5%-43% of …